Shubham | SEBI RA @ShubInvests

@Aditya_Hujband Many many congratulations Bro ! ❤️👏 5K is just the beginning, many more milestones to come. Keep growing and inspiring! 🚀📈

🏛️ THE MOST INTERESTING PART OF THE NSE IPO ISN’T THE IPO. Think about this: You trade on NSE. Your broker connects to NSE. Your mutual fund trades through the market. Nifty is an NSE product. F&O activity happens on NSE. Now the exchange itself is coming to the public market. IPO: ₹22,561 Cr | ₹1,700–₹1,785 But here's the twist: 👉 NSE gets ZERO fresh capital. It is a 100% OFS. Existing shareholders are selling. So you're not funding NSE's growth. You're buying a piece of an already extremely profitable market infrastructure business. And the numbers explain why investors are interested: 📊 92.99% cash-market share 📊 99.79% equity-futures share 💰 FY26 PAT: ₹10,302 Cr 📈 PAT margin: ~55% 📈 ROE: 33.21% 📈 ROCE: 42.80% Valuation: ~43x P/E. That's NOT cheap. But here's my question: **Would you rather buy a ₹4.4 lakh crore monopoly-like franchise at 43x earnings… or a cheaper company with much weaker competitive advantages?** Because IPO investing isn't about: ❌ “Is NSE expensive?” It's about: ✅ “Is NSE expensive relative to the quality and durability of its earnings?” And there is another interesting angle: Several listed institutions already own NSE shares. The IPO could potentially make those hidden holdings more visible to the market. I like the business more than I like the valuation. Now I want your honest answer: Would you apply for NSE at ₹1,785? 👇 YES — Quality justifies the premium or NO — 43x P/E is too expensive Comment YES / NO + WHY. Let's see where the market stands before the IPO opens.

Lohia Corp: Is the market underestimating the earnings story? A machinery company with ~40.7% India market share and ~15.4% global share is showing a sharp fundamental improvement. ₹1,778 Cr order book, Revenue +59.7% YoY, EBITDA +167.7% , PAT +292.3%, EBITDA margin ~20%, ROCE 52.3% , Debt down to ₹48 Cr The interesting part isn't just the growth. It's the combination of market position + order visibility + margin expansion + cash generation + improving balance sheet. At the report's CMP of ₹565.50, the valuation also raises an important question: has the market already priced in the improvement, or is it still underestimating the company's potential earnings base? But the thesis needs to be tested. Can 20% margins sustain? Can the ₹1,778 Cr order book convert into revenue and cash? Can Lohia defend its moat against cheaper Chinese competitors? Can recycling and after-market revenue become meaningful growth engines? And don't ignore the risks: low liquidity, capital-goods cyclicality, margin normalisation, plastic-packaging disruption, Chinese competition, recycling execution and governance information that still requires verification. For me, this is not simply a “buy” story. It is a company worth watching quarter after quarter and testing against the numbers. Research > narrative. Evidence > excitement. #LohiaCorp #StockMarket #IndianStocks #FundamentalAnalysis

Rishabh Instruments: ₹692 → ₹796 📈 ~15% up since my original post. I wrote about the company when it was at ₹692. Today: ₹796 | +8% today. 🚀 This is exactly why I focus on research before the price moves. The thesis remains the same understand the business, identify the moat, track the numbers, and let the market do its job. Research first. Price later. 📊

Shubham | SEBI RA @ShubInvests

2 months ago

🏰 WHY IS RISHABH INSTRUMENTS INTERESTING? Forget the stock price for a moment. What would it take to build Rishabh's business from scratch today? 🤔 ⏳ 40+ years of manufacturing experience 🌍 Presence across 100+ countries 🏭 5 manufacturing facilities 🔬 7 R&D centres 📜

0 1 1 526 0

Crude: “Hello, I’m back.” Brent: ~$95+ US-Iran tensions: “Hold my portfolio.” Market opened like it had seen the electricity bill... Then recovered from the lows and closed near 23,914. Meanwhile investors: Morning: “Buy the dip!” Afternoon: “Which dip?” Closing bell: “Maybe tomorrow.” And somewhere in the market, Coal India was sitting there like: “Everyone worried about oil? I’ll take the spotlight.” Lesson of the day: In markets, sometimes the biggest risk isn’t your stock. It’s something happening thousands of kilometres away that suddenly decides your stock should have a bad day. #Nifty50 #StockMarket #IndianStockMarket #Investing #DalalStreet #Markets #Nifty500

🚨 What if the future of cancer treatment is NOT one drug for millions of people ? But millions of different drugs one for each patient. Moderna & Merck are testing a personalised cancer vaccine that starts with the patient’s own tumour. Here’s the fascinating part: → Sequence the tumour → Find its unique mutations → Select potential cancer targets → Encode them into mRNA → Manufacture a personalised dose The manufacturing challenge completely changes. Traditional pharma = make millions of identical doses. Personalised medicine = make millions of different doses using the same process. And this could be a BIG opportunity for India. India already has strengths in pharma manufacturing, generics and cost efficiency. The next opportunity may not be: “Can India make the same medicine cheaper?” It could be: “Can India make personalised medicine cheaper?” That is a much bigger question. The future of pharma may be about scaling personalisation, not just production. What do you think could India become a global hub for personalised medicine ?

Another day at NSE. Not just standing beside the bull, but remembering what it represents conviction, discipline, patience, and the courage to stay in the game. The market will test all four. #NSE #StockMarket #Investing

🔩 Indo-MIM : A niche manufacturing moat worth watching Indo-MIM operates in Metal Injection Moulding (MIM), a highly specialized process used to manufacture complex precision components for automotive, aerospace, medical, electronics and other high-value applications. The key attraction is scale + specialization. Indo-MIM is one of the largest MIM manufacturers globally, creating a meaningful barrier to entry. 📌 What stands out: • FY26 OCF: ₹1,077 Cr vs ₹533 Cr net profit ~2x cash conversion • FY26 FCF: ₹659 Cr after years of heavy capex • ROCE: 27.74% | ROE: 21.26% • D/E: 0.56x • Interest coverage: 12.24x • Promoter holding: 93.34% The business appears to have moved from a capex-heavy phase toward stronger cash generation. ⚠️ But there are important caveats: limited public disclosures, no 5-year ROCE/ROE trend available, and the reported 889% YoY Q1 revenue growth needs base-effect context. At a ₹44,000 Cr market cap, Indo-MIM is no longer an under-the-radar small-cap story. Strong business + niche global positioning + improving cash generation. Valuation and future growth execution now matter. Not a buy/sell recommendation. DYOR.

One of the stocks I picked early in my journey #cupid became more than just a return. It was one of the moments that reminded me why I chose research. From my early corporate experience to becoming a SEBI Registered Research Analyst, the biggest lesson has been simple: know what you’re looking for before you start looking at the numbers. My research, conviction and patience in CUPID delivered ~1,475% returns from my chosen entry. The return is exciting, but the journey behind that conviction means more. 📈 Still learning. Still researching. Still building. This is just one chapter of my journey as a SEBI RA. 🚀 Not a recommendation. Past performance is not indicative of future returns.

🏰 WHY IS RISHABH INSTRUMENTS INTERESTING? Forget the stock price for a moment. What would it take to build Rishabh's business from scratch today? 🤔 ⏳ 40+ years of manufacturing experience 🌍 Presence across 100+ countries 🏭 5 manufacturing facilities 🔬 7 R&D centres 📜 Global certifications 🇪🇺 European presence through Lumel 🤝 Established industrial customers And the numbers are getting interesting: 📈 FY26 Revenue: ₹267.6 Cr 💰 EBITDA: ₹60.4 Cr 🔥 EBITDA Margin: 22.6% 📊 PAT: ₹41.7 Cr But here's the interesting part: A competitor can copy a product. Can it copy 40 years of manufacturing know-how, certifications, customer relationships, R&D and global distribution? That's where the moat starts. 🏰 🚀 What I’m watching next: • Can revenue growth remain strong? • Can ~20%+ EBITDA margins sustain? • Can ROCE/ROE continue recovering? • Can US + Europe become bigger growth engines? • Can new products create the next leg of growth? 💡 My takeaway: The biggest competitive advantage may not be what Rishabh sells today but the ecosystem it has built to keep selling globally tomorrow. Would you call this a genuine moat, or simply a good manufacturing business? 👇 #RishabhInstruments #SmallCap #Manufacturing #Electrical #Investing

🚨 Omnitech Engineering Ltd (OMNI) @ ₹579 — Potential Multibagger? Sometimes the interesting part isn't the stock price. It's what the company is quietly building behind it. OMNI has a ₹3,000+ Cr order book, 256+ global customers, 5-micron precision capabilities and exposure to Aerospace ✈️, Energy ⚡, Automation ⚙️ & China+1 🇮🇳. Q1 FY27 revenue grew ~65% YoY, while profit jumped ~468%. EBITDA margins are above 30%. But the real story is ahead: Can OMNI convert its order book into revenue, revenue into cash, reduce debt and compound earnings for years? 👀 That's why I see potential multibagger characteristics — not because OMNI is cheap, but because the business could become much larger. ⚠️ P/E ~70x | D/E ~2.2x | FY25 OCF negative. The next few quarters will matter more than the last one. Educational research only. Not investment advice. #OMNI #Multibagger #SmallCap #IndianStocks

SEBI’s SME Listing Overhaul: A Necessary Reset? SEBI is reportedly considering a significant overhaul of the SME listing framework, with tighter eligibility, greater transparency and stronger safeguards against price manipulation. From an investor’s perspective, this is an important development. The SME segment can give promising businesses access to public capital at an early stage. But the same segment can also carry higher liquidity, valuation and price manipulation risks. The real challenge is finding the right balance: Stricter enough to protect investors. Flexible enough to support genuine entrepreneurs. For me, the key question is not whether SME regulations should become stricter. It is: Can SEBI design a framework where genuine businesses get capital, while speculative activity becomes harder? What would you prioritise in the new SME framework? 1. Stronger eligibility criteria 2. Better disclosure requirements 3. Stricter promoter/investor safeguards 4. Greater surveillance of price & volume activity

KSH International: Strong FY26, Bigger Growth Plans $KSHINTL is emerging as an interesting play on India’s power T&D, renewable energy and transformer capex cycle.📊 FY26 Performance • Revenue: ₹3,107 Cr | +61% YoY • PAT: ₹110 Cr | +62% YoY • EBITDA: ₹190 Cr • EBITDA/ton: ₹67,600 • Debt/EBITDA: 0.39x vs 1.21x🔥 Q4 FY26 • Revenue: ₹1,018 Cr | +101% YoY • PAT: ₹34.5 Cr | +87% YoY • EBITDA/ton: ₹74,000🏗️ Future Plans • Capacity: 43,445 MT → ~59,000 MT by FY27 • Additional ~10,000 MT potential capacity • PEEK insulated wires for 800V EV traction motors • Green copper backward integration targeted for H2 FY27 • Export contribution targeted toward ~40%⚡ With ~75% revenue from specialized wires, KSH is positioned in CTC and other high-value winding wire applications across transformers, T&D, renewables and data centres. ⚠️ Key risks: Customer concentration, supplier concentration, power-sector dependence and product concentration remain important factors to monitor.

🚀 AZAD ENGINEERING - A STORY BEYOND NUMBERS What if the next big manufacturing story is hiding inside the engines that power aircraft, turbines and defence systems? ✈️⚡🛡️ That is where Azad Engineering enters the picture. The company manufactures highly specialised precision components used in aerospace, defence, energy and oil & gas, supplying global giants such as GE Vernova, Siemens Energy, Mitsubishi Heavy Industries, Rolls-Royce, Honeywell, Boeing and HAL. But the interesting part is what is happening behind the scenes. 📦 ₹6,500 Cr order book gives the business significant revenue visibility. ✈️ Aerospace & Defence is accelerating, with FY25 revenue growth of around 84%, much faster than its traditional Energy & Oil & Gas business. 🏭 Capacity is expanding aggressively, with dedicated facilities for major customers and a new manufacturing facility planned at Tuniki Bollaram, Hyderabad. 💰 The company has also raised ₹700 Cr through QIP, with a major portion directed toward machinery, equipment and automation. The bigger opportunity is the combination of India's defence push + global aviation demand + power generation + precision manufacturing. But every growth story has another side. ⚠️ Working capital remains high. ⚠️ Expansion brings execution risk. ⚠️ Capacity utilisation needs to improve. ⚠️ Order-book conversion will be critical. So the real question isn't simply “How big is the order book?” The real question is: Can Azad convert this order book into sustainable revenue, profits and cash flow? That is the story worth watching. 👀 Azad Engineering from precision components to a potential global engineering platform.

🚀 Freshara Agro Exports Research Update I researched Freshara at ₹164 in Feb 2025. 📈 CMP now: ~₹361 🔥 Gain from research price: ~120%

Shubham | SEBI RA @ShubInvests

2 years ago

🚀 Freshara Agro Exports Ltd: A Small-Cap with Global Ambitions! 🔹 CMP: ₹164 | MCap: ₹385 Cr | P/E: 41.2 🔹 Strong Export Play – Serving global markets with preserved gherkins & pickled veggies. 🌱 🔹 High Promoter Holding – 62.58% confidence in business! 💪

1 0 4 924 0

🚨 Sky Gold & Diamonds The Story Has Changed! Back in Feb 2025, we highlighted SKYGOLD at ₹348 with a ₹488 target. Today, the stock is around ₹800 more than 2X from that level.

Shubham | SEBI RA @ShubInvests

2 years ago

🚀 Skygold (NSE: SKYGOLD) in the spotlight! 🎯 CMP: ₹348 | Target: ₹488 (45 days) 🔻 Stoploss: ₹290 🏆 B2B supplier to Malabar, Joyalukkas, Kalyan & more 🤝 New tie-up with Aditya Birla for jewellery venture

0 0 1 736 0